logo

For the Inventor, By the Inventor

Lake Forest, IL, United States of America

Horizon Orphan LLC


USPTO Granted Patents = 18

% Expired Patents = 22.2



Trademarks = 2

Forward Citations = 35

Loading Chart...
Loading Chart...

23 inventors (with patents filed for the assignee):

goldMedal Michael N Dudley (8 out of 36 patents)

silverMedal David C Griffith (8 out of 36 patents)

bronzeMedal Olga Rodny (5 out of 27 patents)

4.  Todd C Zankel (5 out of 16 patents)

5.  Mark William Surber (4 out of 37 patents)

6.  Keith A Bostian (4 out of 17 patents)

7.  Mark Johnson (4 out of 4 patents)

8.  Olga Lomovskaya (3 out of 19 patents)

9.  Michael A Desjardin (3 out of 10 patents)

10.  Jeffery S Loutit (3 out of 3 patents)

11.  Elizabeth E Morgan (3 out of 3 patents)

12.  Benoit Gourdet (2 out of 8 patents)

13.  John Francis Unitt (2 out of 4 patents)

14.  Timothy Phillips (2 out of 2 patents)

15.  Lorna Duffy (2 out of 11 patents)


18 patents:

1. 11505550 - ADO-resistant cysteamine analogs and uses thereof (2022-11-22),
2. 11090279 - Delayed release cysteamine bead formulation, and methods of making and using same (2021-08-17),
3. 11020481 - Topical use of levofloxacin for reducing lung inflammation (2021-06-01),
4. 10987357 - Aerosolized fluoroquinolones and uses thereof (2021-04-27),
5. 10906904 - ADO-resistant cysteamine analogs and uses thereof (2021-02-02),
6. 10905662 - Methods for storing cysteamine formulations and related methods of treatment (2021-02-02),
7. 10792289 - Use of aerosolized levofloxacin for treating cystic fibrosis (2020-10-06),
8. 10722519 - Aerosol fluoroquinolone formulations for improved pharmacokinetics (2020-07-28),
9. 10548859 - Methods for storing Cysteamine formulations and related methods of treatment (2020-02-04),
10. 10328037 - Methods for storing cysteamine formulations and related methods of treatment (2019-06-25),
11. 10308607 - Fucosidase inhibitors (2019-06-04),
12. 10231975 - Use of aerosolized levofloxacin for treating cystic fibrosis (2019-03-19),
13. 10149854 - Aerosol fluoroquinolone formulations for improved pharmacokinetics (2018-12-11),
14. 10143665 - Methods for storing cysteamine formulations and related methods of treatment (2018-12-04),
15. 9951013 - Fucosidase inhibitors (2018-04-24),
Horizon Orphan LLC is a pharmaceutical company specializing in developing innovative treatments for rare and orphan diseases. Our dedicated team of scientists and researchers work relentlessly to discover and develop groundbreaking therapies that address unmet medical needs. With a strong focus on patient welfare, Horizon Orphan is committed to delivering high-quality medications that improve the lives of individuals with rare diseases.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Horizon Orphan LLC
18 Patents

#18 in Lake Forest, IL

#915 in Illinois

#17,933 in US

#34,146 in the World

Lake Forest, IL (US)
Lake Forest, IL, United States of America

Horizon Orphan LLC

Forward Citations = 35

23 inventors:

goldMedal Michael N Dudley (8 out of 36 patents)

silverMedal David C Griffith (8 out of 36 patents)

bronzeMedal Olga Rodny (5 out of 27 patents)

4.  Todd C Zankel (5 out of 16 patents)

5.  Mark William Surber (4 out of 37 patents)

Please report any incorrect information to [email protected]
Loading…